“Down Staging of Cirrhosis in All Cirrhotic Patients with HCV Genotype 3-a Infection, Treated with 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin” (2024) Medical Forum Monthly, 29(3). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/2891 (Accessed: 16 November 2025).